The IRE1α Inhibitor KIRA6 Blocks Leukotriene Biosynthesis in Human Phagocytes

The ER stress and Unfolded Protein Response (UPR) component inositol-requiring enzyme 1α (IRE1α) has been linked to inflammation and lipid mediator production. Here we report that the potent IRE1α inhibitor, KIRA6, blocks leukotriene biosynthesis in human phagocytes activated with lipopolysaccharide...

Full description

Bibliographic Details
Main Authors: Xiao Tang, Tarvi Teder, Bengt Samuelsson, Jesper Z. Haeggström
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.806240/full
_version_ 1811335726018592768
author Xiao Tang
Tarvi Teder
Bengt Samuelsson
Jesper Z. Haeggström
author_facet Xiao Tang
Tarvi Teder
Bengt Samuelsson
Jesper Z. Haeggström
author_sort Xiao Tang
collection DOAJ
description The ER stress and Unfolded Protein Response (UPR) component inositol-requiring enzyme 1α (IRE1α) has been linked to inflammation and lipid mediator production. Here we report that the potent IRE1α inhibitor, KIRA6, blocks leukotriene biosynthesis in human phagocytes activated with lipopolysaccharide (LPS) plus N-formyl-methionyl-leucyl-phenylalanine (fMLP) or thapsigargin (Tg). The inhibition affects both leukotriene B4 (LTB4) and cysteinyl leukotriene (cys-LTs) production at submicromolar concentration. Macrophages made deficient of IRE1α were still sensitive to KIRA6 thus demonstrating that the compound’s effect on leukotriene production is IRE1α-independent. KIRA6 did not exhibit any direct inhibitory effect on key enzymes in the leukotriene pathway, as assessed by phospholipase A2 (PLA2), 5-lipoxygenase (5-LOX), LTA4 hydrolase (LTA4H), and LTC4 synthase (LTC4S) enzyme activity measurements in cell lysates. However, we find that KIRA6 dose-dependently blocks phosphorylation of p38 and ERK, mitogen-activated protein kinases (MAPKs) that have established roles in activating cytosolic PLA2α (cPLA2α) and 5-LOX. The reduction of p38 and ERK phosphorylation is associated with a decrease in cPLA2α phosphorylation and attenuated leukotriene production. Furthermore, KIRA6 inhibits p38 activity, and molecular modelling indicates that it can directly interact with the ATP-binding pocket of p38. This potent and unexpected, non-canonical effect of KIRA6 on p38 and ERK MAPKs and leukotriene biosynthesis may account for some of the immune-modulating properties of this widely used IRE1α inhibitor.
first_indexed 2024-04-13T17:28:38Z
format Article
id doaj.art-48e659b7dce745d3b1c318fd69d1d374
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T17:28:38Z
publishDate 2022-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-48e659b7dce745d3b1c318fd69d1d3742022-12-22T02:37:39ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-03-011310.3389/fphar.2022.806240806240The IRE1α Inhibitor KIRA6 Blocks Leukotriene Biosynthesis in Human PhagocytesXiao TangTarvi TederBengt SamuelssonJesper Z. HaeggströmThe ER stress and Unfolded Protein Response (UPR) component inositol-requiring enzyme 1α (IRE1α) has been linked to inflammation and lipid mediator production. Here we report that the potent IRE1α inhibitor, KIRA6, blocks leukotriene biosynthesis in human phagocytes activated with lipopolysaccharide (LPS) plus N-formyl-methionyl-leucyl-phenylalanine (fMLP) or thapsigargin (Tg). The inhibition affects both leukotriene B4 (LTB4) and cysteinyl leukotriene (cys-LTs) production at submicromolar concentration. Macrophages made deficient of IRE1α were still sensitive to KIRA6 thus demonstrating that the compound’s effect on leukotriene production is IRE1α-independent. KIRA6 did not exhibit any direct inhibitory effect on key enzymes in the leukotriene pathway, as assessed by phospholipase A2 (PLA2), 5-lipoxygenase (5-LOX), LTA4 hydrolase (LTA4H), and LTC4 synthase (LTC4S) enzyme activity measurements in cell lysates. However, we find that KIRA6 dose-dependently blocks phosphorylation of p38 and ERK, mitogen-activated protein kinases (MAPKs) that have established roles in activating cytosolic PLA2α (cPLA2α) and 5-LOX. The reduction of p38 and ERK phosphorylation is associated with a decrease in cPLA2α phosphorylation and attenuated leukotriene production. Furthermore, KIRA6 inhibits p38 activity, and molecular modelling indicates that it can directly interact with the ATP-binding pocket of p38. This potent and unexpected, non-canonical effect of KIRA6 on p38 and ERK MAPKs and leukotriene biosynthesis may account for some of the immune-modulating properties of this widely used IRE1α inhibitor.https://www.frontiersin.org/articles/10.3389/fphar.2022.806240/fullleukotrienesKIRA6inflammationIRE1αMAPKs
spellingShingle Xiao Tang
Tarvi Teder
Bengt Samuelsson
Jesper Z. Haeggström
The IRE1α Inhibitor KIRA6 Blocks Leukotriene Biosynthesis in Human Phagocytes
Frontiers in Pharmacology
leukotrienes
KIRA6
inflammation
IRE1α
MAPKs
title The IRE1α Inhibitor KIRA6 Blocks Leukotriene Biosynthesis in Human Phagocytes
title_full The IRE1α Inhibitor KIRA6 Blocks Leukotriene Biosynthesis in Human Phagocytes
title_fullStr The IRE1α Inhibitor KIRA6 Blocks Leukotriene Biosynthesis in Human Phagocytes
title_full_unstemmed The IRE1α Inhibitor KIRA6 Blocks Leukotriene Biosynthesis in Human Phagocytes
title_short The IRE1α Inhibitor KIRA6 Blocks Leukotriene Biosynthesis in Human Phagocytes
title_sort ire1α inhibitor kira6 blocks leukotriene biosynthesis in human phagocytes
topic leukotrienes
KIRA6
inflammation
IRE1α
MAPKs
url https://www.frontiersin.org/articles/10.3389/fphar.2022.806240/full
work_keys_str_mv AT xiaotang theire1ainhibitorkira6blocksleukotrienebiosynthesisinhumanphagocytes
AT tarviteder theire1ainhibitorkira6blocksleukotrienebiosynthesisinhumanphagocytes
AT bengtsamuelsson theire1ainhibitorkira6blocksleukotrienebiosynthesisinhumanphagocytes
AT jesperzhaeggstrom theire1ainhibitorkira6blocksleukotrienebiosynthesisinhumanphagocytes
AT xiaotang ire1ainhibitorkira6blocksleukotrienebiosynthesisinhumanphagocytes
AT tarviteder ire1ainhibitorkira6blocksleukotrienebiosynthesisinhumanphagocytes
AT bengtsamuelsson ire1ainhibitorkira6blocksleukotrienebiosynthesisinhumanphagocytes
AT jesperzhaeggstrom ire1ainhibitorkira6blocksleukotrienebiosynthesisinhumanphagocytes